Medtronic (NYSE: MDT) announced today that it received CE mark approval for its Penditure LAA exclusion system.

Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, ...

Left atrial appendage closure offers promising ischaemic outcomes in patients with atrial fibrillation who refuse to take ...

The data aren’t definitive, but continuing OAC or switching to another drug doesn’t seem to be enough for this high-risk ...

Boston Scientific also foresees future growth in its Watchman business from a planned label expansion and concomitant ...

The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.

Mumbai: Holy Family Hospital, Bandra, has launched three dedicated cardiac clinics to provide precise diagnosis and advanced ...

For persistent or longstanding persistent Afib, one-shot epicardial and endocardial ablation with left atrial appendage ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published a comprehensive roadmap that details the use ...

Holy Family Hospital, Bandra, has launched three cardiac clinics to provide diagnosis and advanced treatment for complex ...